|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on May 28, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.13 last updated Fri Jul 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Iterum Therapeutics.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.